PREMIUM: Alarm bells continue to ring in the West over Chinese state-owned enterprises
A U-turn from the UK, as seen in last month’s Integrated Review, typifies concern over the risk of Chinese interference in strategically important industries.
President Donald Trump’s decision announced on 20 October to pull out of the Intermediate-Range Nuclear Forces (INF) Treaty – a voluntary bilateral agreement between Russia and the US – was blamed on Moscow’s violations of the treaty.
To read this article, along with thousands of others like it, start your Premium News free trial.
Start Trial or log in hereA U-turn from the UK, as seen in last month’s Integrated Review, typifies concern over the risk of Chinese interference in strategically important industries.
Minuteman engineering and programme management support deal is worth $2.31 billion.
New sustainment plans could see Lockheed Martin reduce operating costs of the F-35 to $25,000 per flight hour.
Some €600 million is being spent in Germany on a range of defence procurement initiatives.
Design research work is underway in Russia on a new ICBM to replace the RS-24 Yars.
DARPA is working with industry on 'unburdening the warfighter' by developing advanced and ultra-lightweight personal protective equipment. Its Personalized Protective Biosystems programme pre-dates COVID-19, but it arguably assumes even greater importance for defence procurement in the context of the pandemic.